4.3 Review

Treatment of Fibromyalgia Syndrome: Recommendations of Recent Evidence-Based Interdisciplinary Guidelines with Special Emphasis on Complementary and Alternative Therapies

出版社

HINDAWI LTD
DOI: 10.1155/2013/485272

关键词

-

资金

  1. Biovale
  2. Janssen
  3. Lilly
  4. Pfizer
  5. Purdue
  6. Valeant
  7. Abbott
  8. Daiichi Sankyo

向作者/读者索取更多资源

Objective. Current evidence indicates that there is no single ideal treatment for fibromyalgia syndrome (FMS). First choice treatment options remain debatable, especially concerning the importance of complementary and alternative medicine (CAM) treatments. Methods. Three evidence-based interdisciplinary guidelines on FMS in Canada, Germany, and Israel were compared for their first choice and CAM-recommendations. Results. All three guidelines emphasized a patient-tailored approach according to the key symptoms. Aerobic exercise, cognitive behavioral therapy, and multicomponent therapy were first choice treatments. The guidelines differed in the grade of recommendation for drug treatment. Anticonvulsants (gabapentin, pregabalin) and serotonin noradrenaline reuptake inhibitors (duloxetine, milnacipran) were strongly recommended by the Canadian and the Israeli guidelines. These drugs received only a weak recommendation by the German guideline. In consideration of CAM-treatments, acupuncture, hypnosis/guided imagery, and Tai Chi were recommended by the German and Israeli guidelines. The Canadian guidelines did not recommend any CAM therapy. Discussion. Recent evidence-based interdisciplinary guidelines concur on the importance of treatment tailored to the individual patient and further emphasize the need of self-management strategies (exercise, and psychological techniques).

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Anesthesiology

Cannabis use disorder in patients with chronic pain: overestimation and underestimation in a cross-sectional observational study in 3 German pain management centres

Patric Bialas, Claudia Boettge-Wolpers, Mary-Ann Fitzcharles, Sven Gottschling, Dieter Konietzke, Stephanie Juckenhoefel, Albrecht Madlinger, Patrick Welsch, Winfried Haeuser

Summary: There are concerns about the development of cannabis use disorder (CUD) in patients using medical cannabis for chronic pain. The current diagnostic criteria for CUD may not accurately identify patients using cannabis for therapeutic reasons. Alternative strategies are needed to determine the true prevalence of CUD in chronic pain patients treated with medical cannabis. In a study conducted in three German pain centers, the prevalence of CUD in chronic pain patients prescribed medical cannabis was assessed using anonymous questionnaires.
Article Neurosciences

Cytokine expression profiles in white blood cells of patients with small fiber neuropathy

Luisa Kress, Nadine Egenolf, Claudia Sommer, Nurcan Uceyler

Summary: This study found higher gene expression of the anti-inflammatory cytokines IL-2, IL-8, and TNF in white blood cells of patients with SFN compared to healthy controls. The combination of these three cytokines had high diagnostic accuracy. Furthermore, female patients showed higher gene expression levels of IL-8 and TNF. IL-2 gene expression was negatively correlated with current pain intensity, and IL-10 gene expression differed between different types of pain.

BMC NEUROSCIENCE (2023)

Article Clinical Neurology

Anti-pan-neurofascin antibodies induce subclass-related complement activation and nodo-paranodal damage

Luise Appeltshauser, Helena Junghof, Julia Messinger, Janis Linke, Axel Haarmann, Ilya Ayzenberg, Panoraia Baka, Johannes Dorst, Anna L. Fisse, Thomas Grueter, Valerie Hauschildt, Alexander Joerk, Frank Leypoldt, Mathias Maeurer, Edgar Meinl, Sebastian Michels, Jeremias Motte, Kalliopi Pitarokoili, Mark Stettner, Carmen Villmann, Marc Weihrauch, Gabriel S. Welte, Inga Zerr, Katrin G. Heinze, Claudia Sommer, Kathrin Doppler

Summary: Autoimmune neuropathy associated with antibodies against pan-neurofascin is a new subtype of nodo-paranodopathy that is associated with high morbidity and mortality. The underlying pathology and long-term prognosis of this condition are not well understood. Understanding the pathogenic mechanism of this disease may have direct implications for its treatment.
Article Clinical Neurology

Glutamic acid decarboxylase antibody-associated neurological syndromes: Clinical and antibody characteristics and therapy response

Marie Madlener, Christine Strippel, Franziska S. Thaler, Kathrin Doppler, Klaus P. Wandinger, Jan Lewerenz, Marius Ringelstein, Rosa Roessling, Til Menge, Jonathan Wickel, Christoph Kellingshaus, Sigrid Mues, Andrea Kraft, Andreas Linsa, Simone C. Tauber, Florian Then Berg, Stefan T. Gerner, Asterios Paliantonis, Alexander Finke, Josef Priller, Ingo Schirotzek, Marie Suesse, Kurt W. Suehs, Christian Urbanek, Makbule Senel, Claudia Sommer, Tania Kuempfel, Harald Pruess, Gereon R. Fink, Frank Leypoldt, Nico Melzer, Michael P. Malter

Summary: This study investigated 101 patients with suspected autoimmune neurological syndromes (AINS) associated with glutamic acid decarboxylase (GAD) antibodies. The results showed that immunotherapy had moderate effectiveness in these patients, and serum GAD antibody levels and intrathecal GAD antibody synthesis did not predict clinical characteristics or treatment outcomes.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2023)

Article Endocrinology & Metabolism

Patient reported quality of life and medication adherence in Fabry disease patients treated with migalastat: A prospective, multicenter study

Jonas Muentze, Kolja Lau, Markus Cybulla, Eva Brand, Tereza Cairns, Lora Lorenz, Nurcan Ueceyler, Claudia Sommer, Christoph Wanner, Peter Nordbeck

Summary: This study investigated therapy adherence and patient-reported outcomes in Fabry disease patients receiving migalastat treatment. The results showed that almost all patients demonstrated high therapy adherence, and there was improvement in pain and physical limitations during the treatment.

MOLECULAR GENETICS AND METABOLISM (2023)

Article Rheumatology

Emotion regulation and the salience network: a hypothetical integrative model of fibromyalgia

Ana Margarida Pinto, Rinie Geenen, Tor D. Wager, Mark A. Lumley, Winfried Hauser, Eva Kosek, Jacob N. Ablin, Kirstine Amris, Jaime Branco, Dan Buskila, Joao Castelhano, Miguel Castelo-Branco, Leslie J. Crofford, Mary-Ann Fitzcharles, Marina Lopez-Sola, Mariana Luis, Tiago Reis Marques, Philip J. Mease, Filipe Palavra, Jamie L. Rhudy, Lucina Q. Uddin, Paula Castilho, Johannes W. G. Jacobs, Jose A. P. da Silva

Summary: This article presents a new model called FITSS (Fibromyalgia: Imbalance of Threat and Soothing Systems), which proposes that an imbalance in emotion regulation, specifically an overactive 'threat' system and underactive 'soothing' system, may contribute to the development of fibromyalgia. This model provides a new perspective for future research and may stimulate the discovery of novel therapeutic interventions.

NATURE REVIEWS RHEUMATOLOGY (2023)

Letter Cardiac & Cardiovascular Systems

Tafamidis for cardiac transthyretin amyloidosis: application in a real-world setting in Germany

Caroline Morbach, Aikaterini Papagianni, Sandra Ihne-Schubert, Vladimir Cejka, Maximilian Steinhardt, Georg Fette, Melissa Held, Andreas Geier, Hermann Einsele, Stefan Frantz, Stefan Knop, Claudia Sommer, Stefan Stoerk

CLINICAL RESEARCH IN CARDIOLOGY (2023)

Editorial Material Clinical Neurology

European Journal of Neurology will flip to open access in January 2024

Didier Leys, Claudia Sommer, Paul Boon

EUROPEAN JOURNAL OF NEUROLOGY (2023)

Article Biochemistry & Molecular Biology

Local Inflammatory Mediators Involved in Neuropathic Pain

Patricia Garcia-Fernandez, Colette Reinhold, Nurcan Ueceyler, Claudia Sommer

Summary: Polyneuropathy (PNP) refers to diseases of the peripheral nervous system, with 50% of cases presenting with neuropathic pain. Certain types of PNP show pain restricted to the distal leg skin, indicating a local regulatory process leading to pain. This study suggests that a pro-inflammatory pathway mediated by NF-κB may contribute to pain development in patients with painful PNP. Our findings support the hypothesis of local inflammatory processes involved in pain in PNP, and suggest disrupted anti-inflammatory pathways in inflammatory PNP involving TRPV1 and SIRT1.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Clinical Neurology

Neurofilament light chain levels indicate acute axonal damage under bortezomib treatment

Nadine Cebulla, Daniel Schirmer, Eva Runau, Leon Flamm, Sonja Gommersbach, Helena Stengel, Xiang Zhou, Hermann Einsele, Ann-Kristin Reinhold, Bruno Rogalla von Bieberstein, Daniel Zeller, Heike Rittner, K. Martin Kortuem, Claudia Sommer

Summary: This study aimed to evaluate the relationship between serum levels of neurofilament light chain (NfL) and the characteristics of BTZ-induced peripheral neuropathy (BIPN). The study found that both patients with ongoing BTZ treatment and patients with previous BTZ treatment had higher serum NfL levels compared to controls, and patients with ongoing BTZ treatment had higher NfL levels than patients with past treatment. Serum NfL levels correlated with electrophysiological measures of axonal damage in the group with ongoing BTZ treatment.

JOURNAL OF NEUROLOGY (2023)

Article Clinical Neurology

Dermal Real-Time Quaking-Induced Conversion Is a Sensitive Marker to Confirm Isolated Rapid Eye Movement Sleep Behavior Disorder as an Early alpha-Synucleinopathy

Anastasia Kuzkina, Celine Panzer, Aline Seger, Daniela Schmitt, Jonas Roessle, Sebastian R. Schreglmann, Henrike Knacke, Elena Salabasidou, Antonia Kohl, Elisabeth Sittig, Michael Barbe, Daniela Berg, Jens Volkmann, Claudia Sommer, Wolfgang H. Oertel, Eva Schaeffer, Michael Sommerauer, Annette Janzen, Kathrin Doppler

Summary: The study assessed the use of RT-QuIC method to detect alpha-synuclein aggregation in skin biopsy samples of iRBD patients. It was found that 97.4% of iRBD patients, 87.2% of PD patients, and 13% of controls showed aggregation of alpha-synuclein. RT-QuIC was more sensitive but less specific compared to immunohistochemistry.

MOVEMENT DISORDERS (2023)

Article Multidisciplinary Sciences

Hyperbaric oxygen therapy compared to pharmacological intervention in fibromyalgia patients following traumatic brain injury: A randomized, controlled trial

Jacob N. N. Ablin, Erez Lang, Merav Catalogna, Valerie Aloush, Amir Hadanny, Keren Doenyas-Barak, Shachar Finci, Nir Polak, Gregory Fishlev, Calanit Korin, Rachel Yehudit Tzidky, Oshra Meir Genuth, Shai Efrati

Summary: This study investigated the utility of Hyperbaric Oxygen therapy (HBOT) for fibromyalgia triggered by traumatic brain injury (TBI). The results showed that HBOT significantly reduced pain symptoms, improved quality of life and pain thresholds, and increased brain activity in frontal and parietal regions associated with executive function and emotional processing.

PLOS ONE (2023)

Article Medicine, General & Internal

The Liver Can Deliver: Utility of Hepatic Function Tests as Predictors of Outcome in COVID-19, Influenza and RSV Infections

Einat Ritter, Eden Shusterman, Lior Prozan, Orli Kehat, Ahuva Weiss Meilik, Oren Shibolet, Jacob Nadav Ablin

Summary: Liver test abnormalities are common in patients with COVID-19 and seasonal respiratory viruses, and are associated with poor clinical outcome. Hepatocellular injury has the greatest prognostic significance 48 h after admission. Failure of liver functions to improve or worsen after 48 h is strongly associated with increased risk of death or ventilation in RSV, COVID-19, and influenza patients.

JOURNAL OF CLINICAL MEDICINE (2023)

Article Anesthesiology

Future perspectives: the next fifty years of the International Association for the Study of Pain

Claudia Sommer, Margarita Calvo, Fernando Cervero, John D. Loeser

Summary: The International Association for the Study of Pain has made important contributions to the understanding and treatment of pain through various activities and is committed to reducing the burden of pain worldwide.
暂无数据